genOway Société anonyme (ALGEN.PA)

EUR 2.81

(0.0%)

Operating Expenses Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual operating expenses in 2023 was 16.73 Million EUR , up 1831.43% from previous year.
  • genOway Société anonyme's latest quarterly operating expenses in 2024 Q2 was 10.01 Million EUR , down 0.0% from previous quarter.
  • genOway Société anonyme reported a annual operating expenses of 930.96 Thousand EUR in annual operating expenses 2022, up 9.73% from previous year.
  • genOway Société anonyme reported a annual operating expenses of 848.38 Thousand EUR in annual operating expenses 2021, down -3.46% from previous year.
  • genOway Société anonyme reported a quarterly operating expenses of 17.98 Million EUR for 2023 FY, up 1831.43% from previous quarter.
  • genOway Société anonyme reported a quarterly operating expenses of 500.53 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of genOway Société anonyme (2023 - 2009)

Historical Annual Operating Expenses of genOway Société anonyme (2023 - 2009)

Year Operating Expenses Operating Expenses Growth
2023 16.73 Million EUR 1831.43%
2022 930.96 Thousand EUR 9.73%
2021 848.38 Thousand EUR -3.46%
2020 878.79 Thousand EUR -90.11%
2019 8.88 Million EUR 12.62%
2018 7.89 Million EUR 49.08%
2017 5.29 Million EUR -12.53%
2016 6.05 Million EUR 6.73%
2015 5.66 Million EUR 5.65%
2014 5.36 Million EUR 8.94%
2013 4.92 Million EUR -37.89%
2012 7.93 Million EUR 19.96%
2011 6.61 Million EUR 138.09%
2010 2.77 Million EUR 36.72%
2009 2.03 Million EUR 0.0%

Peer Operating Expenses Comparison of genOway Société anonyme

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -300.725%
ABIVAX Société Anonyme 127.37 Million EUR 86.859%
Adocia SA 15.62 Million EUR -7.098%
Aelis Farma SA 18.81 Million EUR 11.056%
Biophytis S.A. 14.33 Million EUR -16.781%
Advicenne S.A. 8.21 Million EUR -103.753%
IntegraGen SA 5.35 Million EUR -212.718%
Medesis Pharma S.A. 1.56 Million EUR -969.832%
Neovacs S.A. 10.34 Million EUR -61.823%
NFL Biosciences SA 4.37 Million EUR -282.646%
Plant Advanced Technologies SA 2.76 Million EUR -505.396%
Quantum Genomics Société Anonyme 1.71 Million EUR -874.309%
Sensorion SA 27.05 Million EUR 38.129%
Theranexus Société Anonyme 3 Million EUR -457.017%
TME Pharma N.V. 5.49 Million EUR -204.499%
Valbiotis SA 9.86 Million EUR -69.605%
TheraVet SA 1.64 Million EUR -917.95%
Valerio Therapeutics Société anonyme 20.32 Million EUR 17.627%
DBV Technologies S.A. 89.4 Million EUR 81.278%
Genfit S.A. 54.8 Million EUR 69.458%
GeNeuro SA 14.35 Million EUR -16.584%
Innate Pharma S.A. 64.57 Million EUR 74.077%
Inventiva S.A. 120.18 Million EUR 86.073%
MaaT Pharma SA 21.59 Million EUR 22.501%
MedinCell S.A. 32.92 Million EUR 49.158%
Nanobiotix S.A. 58.92 Million EUR 71.595%
OSE Immunotherapeutics SA 23.58 Million EUR 29.042%
Poxel S.A. 28.76 Million EUR 41.81%
GenSight Biologics S.A. 32.66 Million EUR 48.75%
Transgene SA 31.23 Million EUR 46.405%
Valneva SE 134.92 Million EUR 87.594%